All Research
Page 6 of 10 · 233 reports
A scarce Hong Kong-listed digital-twin pure play that still lost RMB 186 million in 2025, runs negative operating cash flow, and saw gross margin fall from 51.1% to 30.0%; at the current HK$98.55 the stock trades at more than 100x P/S, which has already bought the most distant success in advance. Owner earnings remain negative and the fair buy band is HK$5–10. Rating Avoid: a good story with weak cash flow priced for a future that has not yet shown up in the financials.
A global spirits leader built on the Jack Daniel's family, high gross margins, and a long dividend record. Net sales fell 5% in FY2025 and another 2% over the first nine months of FY2026, with management still guiding to a low-single-digit decline. At roughly $26 the stock sits in the middle of a $24–30 fair-value range, with an ideal buy zone of $20–23. Rating Watch: a high-quality compounder now priced closer to fair value than to a bargain, leaving little margin of safety.
A global diversified holding-company leader: 176 billion in insurance float, 397.4 billion in cash and short-term Treasuries, and 67 billion in net income. The capital-allocation record is excellent, but the Abel era is still unproven. At the current 486.38 dollars, with an ideal entry of 350 to 410 dollars, the margin of safety is not obvious. Rating Hold: a high-quality compounder priced fairly rather than cheaply.
A global alternative asset management platform with $1.304 trillion in AUM and $539.7 billion in perpetual capital. At $118.51, the stock trades at roughly 19.5x economic-interest P/DE, with its quality premium already fully priced in. Rating Watch: a top-tier franchise worth owning, but only at a price that offers a real margin of safety, so wait for a better entry point as fundraising, exits, or valuation multiples reset.
A gateway-city Class A office REIT. At $60.29, the stock trades at 8.87x Price/FFO, 1.86x PB, and a 4.64% dividend yield. Asset quality is better than the industry average, but a demand re-rating plus heavy capex still pressure free cash flow. Rating Watch: a high-quality asset base in a headwind industry, priced fairly rather than cheaply; ideal buy price $40–48.
A packaged-food company with mid-tier brands and a mid-tier moat. At $13.56, the stock trades at roughly 5x FY2025 P/FCF, and it is cheap for good reasons: high leverage, volume pressure, and a new CEO, John Brase, taking over in June. Rating Watch: a cheap cash-flow asset rather than a high-quality compounder, with an ideal buy range of $11 to $13.
Market cap of 1.51 trillion dollars and a trailing P/E near 391x mean the current 426 dollar price already pays for a long-dated Physical AI option; the core auto business is slowing while energy storage gross margin has climbed to 39.5% to become a second profit center. Rating Cautious Neutral: a high-beta transition story that is richly priced today, while a high-convexity upside option on autonomy and robotics stays alive.
A three-part asset: a best-in-class commercial space business, the Starlink cash engine, and an xAI platform option. 2025 revenue reached $18.67 billion, but AI lost $6.36 billion and Q1 capex hit $10.1 billion; the $1.75 trillion IPO target prices the future far too early, so we watch the $0.95–1.20 trillion range. Rating Watch: a top-tier asset saddled with excessive expectations and extremely weak governance.
A highly efficient global value e-commerce platform: a 2025 operating margin of 21.6% and roughly 9.6x PE are not expensive. But Temu has lost its small-parcel policy windfall, while domestic price wars and instant retail squeeze the profit center; with a fair buy range of $70–82 and insufficient margin of safety, Rating Watch: high cash flow and low valuation coexist, but Temu's policy regime and profit center await repricing.
A leader in agricultural supply-chain management, ADM posted $80.3 billion in 2025 revenue but only $1.078 billion in net income attributable to shareholders, on a 34.6x trailing P/E. The cash-flow improvement came largely from working-capital release, while the 2024 internal-control deficiency and the persistent gap between Nutrition's long-term promises and its returns weigh on management credibility. Rating Watch: today's price is a prepayment for a cyclical recovery, not a discounted entry into a steady cash machine.
A high-quality, subscription-heavy cloud security platform: FY2026 Q2 subscription mix at 84%, steady ARR growth, and 3.5 billion in net cash. The catch is price: forward EV/S near 8.2x, P/FCF near 33x, GAAP still in the red, and heavy stock-based compensation that drags down true owner earnings, leaving today's roughly 180 dollars sitting at the low end of an optimistic scenario. Rating Watch: an excellent business at a price that offers conservative investors little margin of safety.
FY2026 subscription revenue is 92% of the total, subscription backlog stands at 28.1 billion dollars, and gross retention is 97%, so business quality is solid. But how you treat stock-based compensation directly determines real shareholder returns, buyback timing has been off (average price 226.62 dollars versus 128.14 today), and the stock looks cheap on P/FCF yet not cheap on a GAAP basis, leaving a thin margin of safety. Rating Watch: a high-quality operator that has not yet earned an unarguable margin of safety.
A combination of streaming, studios, and linear television; 2025 FCF of 3.1 billion gives a 4.6% FCF yield, roughly even with the 4.57% 10-year Treasury. The PSKY merger at $31 per share in cash has shareholder approval, and today's 27.03 already carries an event premium; on standalone operating value the ideal buy range is $12-17, leaving the current price neither cheap nor clean. Rating Watch: a strong-asset company mid-transformation whose price already prices in the deal, with too little standalone margin of safety for a conservative long-term owner.
The global EDA leader, now in the middle of integrating Ansys. FY25 revenue reached 7.054 billion with 77% gross margin and R&D running at 35% of revenue. At 80.9x PE, the current price already bakes in both a successful integration and a failure to commoditize, leaving an ideal buy range of 300 to 380 dollars. Rating Watch: a high-quality business priced with no margin of safety.
A commerce operating system for independent merchants, with 2025 GMV of $378.4 billion, revenue of $11.556 billion, and reported FCF of $2.007 billion; after deducting SBC and capital tied up in lending, conservative owner earnings come to just $1.2 billion, with an ideal buy range of $75-95. Rating Watch: a high-quality compounder whose current price still lacks a sufficient margin of safety on a conservative basis.
A mature consumer-electronics retailer with FY26 free cash flow of about 1.258 billion dollars and a forward P/E near 9.6x, so the stock is not expensive. But Amazon has already overtaken it on share and the moat is narrow, with an ideal buy zone of 50-58 dollars and an insufficient margin of safety. Rating Watch: a cheap, mature cash cow rather than a high-quality compounder, not yet cheap enough to justify a position at today's price.
Baxter makes the hospital essentials—IV fluids, infusion systems, pharmacy compounding, surgical hemostats, hospital beds—that care systems depend on every day, but it is still working through the aftermath of the Hillrom acquisition plus 2025 product-safety and execution problems. At roughly $19.18 the stock sits in the gap between my fair-value and optimistic ranges, making it a turnaround stock to watch rather than a core compounding asset. Rating Watch: a stable-demand but middling-economics supplier whose current price gives conservative investors too little margin of safety.
Ares is an alternative asset management platform: 2025 AUM of 623 billion / FPAUM of 385 billion / management fees of 3.863 billion / FRE of 1.775 billion, with FRE making up 96% of distributable cash. At 124.41 dollars, the stock sits inside our fair-value range, and the margin of safety for new buyers is thin. Rating Watch: a high-quality, moat-widening franchise priced for its growth, where the business is good enough but the price is not generous enough.
Apollo is a compound financial enterprise that bundles alternative asset management, insurance liabilities, and credit origination, posting 2025 FRE of $2.528 billion and SRE of $3.361 billion, with AUM reaching roughly $1.03 trillion by Q1 2026. At the current $128.51 the shares sit in the upper-middle of the conservative range and below fair value, leaving the margin of safety too thin. Rating Watch: a high-quality but highly complex platform worth tracking, where I would wait for a more comfortable entry rather than chase the price.
Amphenol is a leader in connectors and interconnect products, with end markets so fragmented that no single customer exceeds 10% of sales, and 2025 free cash flow of roughly 4.4 billion. At the current 132.06 dollars, the 36.4x P/E and 38.7x P/FCF place it at the upper edge of fair value, leaving the starting valuation already very high. Rating Watch: a high-quality compounder fully priced for excellence, with little margin of safety.
APA is an upstream oil and gas company combining a Suriname GranMorgu option with a US/Egypt/UK asset base. At roughly $38.8 today it sits at the top of its fair-value range, deeply constrained by oil prices, geopolitics, and ongoing capital spending—a cyclical name rather than a long-term compounder. Rating Watch: a passable operator with an attractive option but no durable moat, where the current price offers little margin of safety for a conservative long-term owner.
Arista is the leader in high-end Ethernet switching, combining the EOS software stack with an engineering reputation in cloud data centers, an asset-light model, and powerful free cash flow. At the current 156.22 dollars, the trailing P/E of 48.6x already sits above the upper bound of an optimistic intrinsic value, with high-growth expectations priced in well ahead of time. Rating Watch: a superb business whose price has run ahead of its margin of safety.
Amcor is a global leader in flexible and rigid packaging; after the Berry acquisition net debt sits at 14.266 billion and net leverage at 4.2x, on the high side. At the current 38.38 dollars, forward adjusted PE is just 9.6x with a 6.7% dividend yield, but if integration falls short, returns get squeezed back to mediocre. Rating Watch: a defensible, cash-generative packaging platform whose payoff hinges on Berry synergies landing and deleveraging executing.
Netflix has shifted from burning cash to generating it reliably, with 2025 revenue of $45.18 billion and Owner Earnings of roughly $9.3-9.5 billion. But at $89.30 the stock trades at about 35-40x conservative Owner Earnings, leaving little margin of safety; the ideal buy zone sits at $50-65. Rating Watch: a high-quality platform that is fully priced today and rewards patience over purchase at the current level.